Hologic Hits New 52-Week Low: How to Play the Stock Now?
HOLX touched a new yearly low this week, reflecting market reaction to its mixed Q1 fiscal 2025 results. Still, the stock offers strong rebound potential.
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Hologic (HOLX) stood at $70.20, denoting a -0.13% change from the preceding trading day.
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
In the closing of the recent trading day, Hologic (HOLX) stood at $72.73, denoting a +0.05% change from the preceding trading day.
HOLX Stock Gains Following the Acquisition of Gynesonics
Hologic completes the acquisition of Gynesonics, developer of the Sonata System, for approximately $350 million.
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know
Hologic (HOLX) concluded the recent trading session at $71.74, signifying a -0.49% move from its prior day's close.
Here's Why You Should Retain HOLX Stock in Your Portfolio Now
Hologic's strength in the Surgical wing instills optimism among investors. Yet, currency impacts raise concerns.
Hologic (HOLX) Flat As Market Sinks: What You Should Know
Hologic (HOLX) closed at $72.68 in the latest trading session, marking no change from the prior day.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?
Via an agreement with the CDC, Hologic is set to develop ASRs for launching the H5N1 bird flu test.
Here's Why Hologic (HOLX) Fell More Than Broader Market
Hologic (HOLX) closed the most recent trading day at $70.76, moving -0.99% from the previous trading session.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic Trades at 17.62X P/E: Should You Buy, Sell or Hold the Stock?
Despite the current challenges, HOLX's portfolio strength and international growth prospects make it worth holding on to.
